ID   LB39-MEL
AC   CVCL_F240
SY   LB39
DR   Wikidata; Q54902065
RX   PubMed=10661410;
RX   PubMed=12747757;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Characteristics: Established via a mouse xenograft.
CC   HLA typing: A*02,24; B*07,51; C*w01,w07 (PubMed=12747757).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
RX   PubMed=12747757;
RA   Jager, Elke
RA   Karbach, Julia
RA   Gnjatic, Sacha
RA   Jager, Dirk
RA   Maeurer, Markus J.
RA   Atmaca, Akin
RA   Arand, Michael
RA   Skipper, Jonathan C.A.
RA   Stockert, Elisabeth
RA   Chen, Yao-Tseng
RA   Old, Lloyd John
RA   Knuth, Alexander
RT   "Identification of a naturally processed NY-ESO-1 peptide recognized
RT   by CD8+ T cells in the context of HLA-B51.";
RL   Cancer Immun. 2:12.1-12.13(2002).
//
RX   PubMed=10661410; DOI=10.1016/S1074-7613(00)80163-6;
RA   Morel, Sandra
RA   Levy, Frederic
RA   Burlet-Schiltz, Odile
RA   Brasseur, Francis
RA   Probst-Kepper, Michael
RA   Peitrequin, Anne-Lise
RA   Monsarrat, Bernard
RA   Van Velthoven, Robert
RA   Cerottini, Jean-Charles
RA   Boon, Thierry
RA   Gairin, Jean-Edouard
RA   van den Eynde, Benoit J.
RT   "Processing of some antigens by the standard proteasome but not by the
RT   immunoproteasome results in poor presentation by dendritic cells.";
RL   Immunity 12:107-117(2000).
//